CN1159831A - 含有布氏疏螺旋体ospg的疫苗 - Google Patents

含有布氏疏螺旋体ospg的疫苗 Download PDF

Info

Publication number
CN1159831A
CN1159831A CN95195439A CN95195439A CN1159831A CN 1159831 A CN1159831 A CN 1159831A CN 95195439 A CN95195439 A CN 95195439A CN 95195439 A CN95195439 A CN 95195439A CN 1159831 A CN1159831 A CN 1159831A
Authority
CN
China
Prior art keywords
ospg
borrelia
protein
brucei
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN95195439A
Other languages
English (en)
Chinese (zh)
Inventor
莱因哈德·沃利克
马库斯·M·西蒙
迈克尔·D·克雷默
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Federal German Cancer Research Center
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Federal German Cancer Research Center
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9416667A external-priority patent/GB9416667D0/en
Priority claimed from GBGB9503867.5A external-priority patent/GB9503867D0/en
Application filed by Federal German Cancer Research Center, Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Federal German Cancer Research Center
Publication of CN1159831A publication Critical patent/CN1159831A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
CN95195439A 1994-08-17 1995-08-11 含有布氏疏螺旋体ospg的疫苗 Pending CN1159831A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9416667A GB9416667D0 (en) 1994-08-17 1994-08-17 Vaccines and diagnostics
GB9416667.5 1994-08-17
GB9503867.5 1995-02-25
GBGB9503867.5A GB9503867D0 (en) 1995-02-25 1995-02-25 Vaccines and diagnostics

Publications (1)

Publication Number Publication Date
CN1159831A true CN1159831A (zh) 1997-09-17

Family

ID=26305468

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95195439A Pending CN1159831A (zh) 1994-08-17 1995-08-11 含有布氏疏螺旋体ospg的疫苗

Country Status (12)

Country Link
EP (1) EP0781338A1 (cs)
JP (1) JPH10504455A (cs)
KR (1) KR970705636A (cs)
CN (1) CN1159831A (cs)
AU (1) AU687620B2 (cs)
BR (1) BR9508802A (cs)
CA (1) CA2197712A1 (cs)
CZ (1) CZ42497A3 (cs)
HU (1) HUT77251A (cs)
NZ (1) NZ291818A (cs)
PL (1) PL318672A1 (cs)
WO (1) WO1996005313A1 (cs)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103229055A (zh) * 2010-09-27 2013-07-31 康奈尔大学 莱姆病的诊断方法
CN111196842A (zh) * 2020-01-09 2020-05-26 济南大学 一种外膜转运通道蛋白的非跨膜结构域的表达纯化方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19632862B4 (de) 1996-08-14 2006-08-03 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103229055A (zh) * 2010-09-27 2013-07-31 康奈尔大学 莱姆病的诊断方法
US8946393B2 (en) 2010-09-27 2015-02-03 Cornell University Methods for diagnosing lyme disease
CN111196842A (zh) * 2020-01-09 2020-05-26 济南大学 一种外膜转运通道蛋白的非跨膜结构域的表达纯化方法

Also Published As

Publication number Publication date
WO1996005313A1 (en) 1996-02-22
NZ291818A (en) 1998-09-24
AU687620B2 (en) 1998-02-26
HUT77251A (hu) 1998-03-02
CZ42497A3 (en) 1997-10-15
EP0781338A1 (en) 1997-07-02
AU3345495A (en) 1996-03-07
KR970705636A (ko) 1997-10-09
CA2197712A1 (en) 1996-02-22
PL318672A1 (en) 1997-07-07
BR9508802A (pt) 1997-12-30
JPH10504455A (ja) 1998-05-06

Similar Documents

Publication Publication Date Title
Wallich et al. Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo
Nguyen et al. Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE-or OspF-immunized mice
Liang et al. An immune evasion mechanism for spirochetal persistence in Lyme borreliosis
US6221363B1 (en) Vaccine for the prevention of lyme disease
EP0540457A1 (en) Improvements in Borrelia burgdorferi diagnosis and prophylaxis
EP2283031B1 (en) Lyme disease vaccine
US6486130B1 (en) Immunogenic formulation of OSPC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
EP0536335A1 (en) Compositions and methods for the prevention and diagnosis of lyme disease
WO1988005823A2 (en) Mycobacterium tuberculosis genes encoding protein antigens
PT1194559E (pt) Grupos de borrelia burgdorferi e borrelia afzelii que causam a doença de lyme em seres humanos
Wallich et al. Molecular and immunological characterization of a novel polymorphic lipoprotein of Borrelia burgdorferi
AU683260B2 (en) Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
WO1995004145A1 (en) Novel b. burgdorferi polypeptides
EP3029073B1 (en) Polyvalent chimeric ospc vaccinogen and diagnostic antigen
CN1159831A (zh) 含有布氏疏螺旋体ospg的疫苗
CN104379164A (zh) 治疗狗中的莱姆病的疫苗和方法
RU2102081C1 (ru) Иммуногенная композиция против боррелиоза лайма, способ иммунизации млекопитающего против боррелиоза лайма, способ получения белка pc borrelia burgdorferi, диагностический агент для обнаружения b.burgdorferi и способ обнаружения антител к b.burgdorferi
HK1003060A (en) Vaccines containing borrelia burgdorferi ospg
MXPA97001224A (en) Vaccines against borrelia burgdorferi o
US6716591B1 (en) B. burgdorferi polypeptides
WO1995009919A1 (en) Vaccines and diagnostics for borrelia burgdorferi
Lovett et al. Comparison of Protection in Rabbits
Kumar Characterization of Borrelia burgdorferi gene products critical for pathogen persistence and transmission

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1003060

Country of ref document: HK